MIT chemists successfully synthesised a fungal compound that was discovered 50 years ago and created derivatives that show ...

Inside the UT Health RGV Cancer and Surgery center, there is a new radiation treatment machine, called True Beam, according ...

The M-Strip developed by IOTA Diagnostic uses period blood to screen for high-risk HPV, the main cause of cervical cancer.

Pulse Biosciences has partnered with The University of Texas MD Anderson Cancer Centre to investigate the use of the nPulse ...

GigaTIME is a new AI tool that significantly speeds up the analysis of tumour microenvironments. The tool can computationally simulate the analysis of dozens of proteins in seconds, allowing ...

An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...

Investing in Innovation Africa (i3) has announced three deals that directly connect African healthtech startups with global ...

Mirai Medical announced that it secured approximately $8.4 million (€7.2 million) in funding from the Irish government.

YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer ...

The centre houses an <a href=" Harmony Pro linear accelerator, one of the most advanced radiotherapy systems in the world ...

Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for the management of prostate cancer ...

An announcement from Pulse Biosciences ( ($PLSE) ) is now available. On December 9, 2025, Pulse Biosciences announced a research collaboration ...